A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation - PubMed (original) (raw)
A chimeric EGF-R-neu proto-oncogene allows EGF to regulate neu tyrosine kinase and cell transformation
H Lehväslaiho et al. EMBO J. 1989 Jan.
Abstract
The neu oncogene, characterized by Weinberg and colleagues, is a transforming gene found in ethylnitrosourea-induced rat neuro/glioblastomas; its human proto-oncogene homologue has been termed erbB2 or HER2 because of its close homology with the epidermal growth factor receptor (EGF-R) gene (c-erbB1). Expression of the rat neu oncogene is sufficient for transformation of mouse NIH 3T3 fibroblasts in culture and for the development of mammary carcinomas in transgenic mice, but the neu proto-oncogene has not been associated with cell transformation. We constructed a vector for expression of a chimeric cDNA and hybrid protein consisting of the EGF-R extracellular, transmembrane and protein kinase C-substrate domains linked to the intracellular tyrosine kinase and carboxyl terminal domain of the rat neu cDNA. Upon transfection with the construct, NIH 3T3 cells gave rise to EGF-R antigen-positive cell clones with varying amounts of specific EGF binding. Immunofluorescence and immunoprecipitation using neu- and EGF-receptor specific antibodies demonstrated a correctly oriented and positioned chimeric EGF-R-neu protein of the expected apparent mol. wt on the surface of these cells. EGF or TGF alpha induced tyrosine phosphorylation of the chimeric receptor protein, stimulated DNA synthesis of EGF-R-neu expressing cells and led to a transformed cell morphology and growth in soft agar. In contrast, the neu proto-oncogene did not show kinase activity or transforming properties when expressed at similar levels in NIH 3T3 cells.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- HER2 cytoplasmic domain generates normal mitogenic and transforming signals in a chimeric receptor.
Lee J, Dull TJ, Lax I, Schlessinger J, Ullrich A. Lee J, et al. EMBO J. 1989 Jan;8(1):167-73. doi: 10.1002/j.1460-2075.1989.tb03361.x. EMBO J. 1989. PMID: 2565808 Free PMC article. - A chimeric EGFR/neu receptor in studies of neu function.
Lehtola L, Lehväslaiho H, Koskinen P, Alitalo K. Lehtola L, et al. Cancer Treat Res. 1992;61:213-28. doi: 10.1007/978-1-4615-3500-3_11. Cancer Treat Res. 1992. PMID: 1360234 Review. No abstract available. - Constitutively activated neu oncoprotein tyrosine kinase interferes with growth factor-induced signals for gene activation.
Lehtola L, Sistonen L, Koskinen P, Lehväslaiho H, Di Renzo MF, Comoglio PM, Alitalo K. Lehtola L, et al. J Cell Biochem. 1991 Jan;45(1):69-81. doi: 10.1002/jcb.240450114. J Cell Biochem. 1991. PMID: 1706346 - Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products.
Kokai Y, Dobashi K, Weiner DB, Myers JN, Nowell PC, Greene MI. Kokai Y, et al. Proc Natl Acad Sci U S A. 1988 Aug;85(15):5389-93. doi: 10.1073/pnas.85.15.5389. Proc Natl Acad Sci U S A. 1988. PMID: 2899889 Free PMC article. - The role of non-ras transforming genes in chemical carcinogenesis.
Cooper CS. Cooper CS. Environ Health Perspect. 1991 Jun;93:33-40. doi: 10.1289/ehp.919333. Environ Health Perspect. 1991. PMID: 1685444 Free PMC article. Review.
Cited by
- Antibody-Drug Conjugates for the Treatment of HER2-Positive Breast Cancer.
Najjar MK, Manore SG, Regua AT, Lo HW. Najjar MK, et al. Genes (Basel). 2022 Nov 8;13(11):2065. doi: 10.3390/genes13112065. Genes (Basel). 2022. PMID: 36360302 Free PMC article. Review. - Ab locks for improving the selectivity and safety of antibody drugs.
Lin WW, Lu YC, Chuang CH, Cheng TL. Lin WW, et al. J Biomed Sci. 2020 Jun 25;27(1):76. doi: 10.1186/s12929-020-00652-z. J Biomed Sci. 2020. PMID: 32586313 Free PMC article. Review. - The EGF receptor family--multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4.
Earp HS 3rd, Calvo BF, Sartor CI. Earp HS 3rd, et al. Trans Am Clin Climatol Assoc. 2003;114:315-33; discussion 333-4. Trans Am Clin Climatol Assoc. 2003. PMID: 12813928 Free PMC article. Review. - Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.
Chausovsky A, Tsarfaty I, Kam Z, Yarden Y, Geiger B, Bershadsky AD. Chausovsky A, et al. Mol Biol Cell. 1998 Nov;9(11):3195-209. doi: 10.1091/mbc.9.11.3195. Mol Biol Cell. 1998. PMID: 9802906 Free PMC article. - A hierarchical network of interreceptor interactions determines signal transduction by Neu differentiation factor/neuregulin and epidermal growth factor.
Tzahar E, Waterman H, Chen X, Levkowitz G, Karunagaran D, Lavi S, Ratzkin BJ, Yarden Y. Tzahar E, et al. Mol Cell Biol. 1996 Oct;16(10):5276-87. doi: 10.1128/MCB.16.10.5276. Mol Cell Biol. 1996. PMID: 8816440 Free PMC article.
References
- Science. 1985 Sep 6;229(4717):974-6 - PubMed
- Int J Cancer. 1987 Aug 15;40(2):246-54 - PubMed
- Proc Natl Acad Sci U S A. 1985 Oct;82(19):6497-501 - PubMed
- Science. 1985 Dec 6;230(4730):1132-9 - PubMed
- Cancer Res. 1986 Feb;46(2):907-16 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous